Atara Biotherapeutics Inc. (ATRA)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q2  2023
≡ Seth Klarman - Baupost Group Add 7.12% 26,000 0.02
Q1  2023
≡ Seth Klarman - Baupost Group Add 12.31% 40,000 0.05
Q3  2021
≡ Lee Ainslie - Maverick Capital Add 1.96% 6,045 0.03
Q2  2021
≡ Lee Ainslie - Maverick Capital Add 14.32% 38,610 0.14
Q4  2020
≡ Lee Ainslie - Maverick Capital Add 8.57% 23,129 0.18
Q2  2020
≡ Lee Ainslie - Maverick Capital Add 29.89% 62,168 0.48
≡ Seth Klarman - Baupost Group Add 19.41% 64,525 0.29
Q1  2020
≡ Lee Ainslie - Maverick Capital Add 4.87% 9,658 0.04
Q3  2019
≡ Lee Ainslie - Maverick Capital Add 128.62% 114,859 0.60
≡ Seth Klarman - Baupost Group Add 18.70% 52,356 0.22
Q2  2019
≡ Lee Ainslie - Maverick Capital Add 156.38% 54,468 0.40
≡ Seth Klarman - Baupost Group Add 9.71% 24,779 0.12
Q1  2019
≡ Seth Klarman - Baupost Group Add 2.01% 5,035 0.04
≡ Lee Ainslie - Maverick Capital Buy 34,830 0.46
Q1  2018
≡ Seth Klarman - Baupost Group Add 16.70% 35,800 0.34
Q3  2015
≡ Seth Klarman - Baupost Group Add 11.44% 22,000 0.29
Q2  2015
≡ Seth Klarman - Baupost Group Add 0.97% 1,854 0.04
Q1  2015
≡ Seth Klarman - Baupost Group Add 90.84% 90,694 1.58
Q4  2014
≡ Seth Klarman - Baupost Group Buy 99,836 1.20

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.